Ultrasound screening at 11-14 weeks of pregnancy for diagnosis of placenta accreta in mothers with a history of cesarean section


Submitted: 15 August 2018
Accepted: 3 September 2018
Published: 2 November 2018
Abstract Views: 1151
PDF: 437
HTML: 18
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Ladan Younesi Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran, Islamic Republic of.
  • Zahra Karimi Dehkordi Department of Radiology, Shahid Akbar Abadi Hospital , Iran University of Medical Sciences, Tehran, Iran, Islamic Republic of.
  • Zeinab Safarpour Lima Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran, Islamic Republic of.
  • Ghazaleh Amjad Shahid Akbarabadi Clinical Research Development Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran, Islamic Republic of.

The aim of this study was to add ultrasonographic screening criteria for placenta accreta in patients with cesarean section history at 11-14 weeks of gestation in order to identify those with the high risk of placenta accreta. Consequently, using ultrasound follow-up and confirmation of diagnosis can reduce mortality and morbidity. Pregnant mothers who were referred for routine screening for ultrasonography at 11–14 weeks of gestation were enrolled in the study if they had a history of cesarean section. Of the 184 subjects who were included in the study, 23 of the low-risk groups were excluded from study for some reason such as miscarriage and a lack of required information on the time of delivery. Among the 152 subjects, 27 were classified in the high-risk group (17.7%) and 125 subjects in the low-risk group (82.3%). Only one case in the high risk group was identified in patients with placenta accreta by ultrasound and clinical diagnosis, which has undergone a cesarean section at the gestational age of 35 weeks. There was no relationship between placenta accreta and disease risk, placenta previa, cesarean section, maternal age, and gravidity. Therefore, placenta accreta screening using ultrasonography can identify high-risk individuals at week 14-11 and with subsequent follow-up for improving prenatal prognosis.


Younesi, L., Karimi Dehkordi, Z., Lima, Z. S., & Amjad, G. (2018). Ultrasound screening at 11-14 weeks of pregnancy for diagnosis of placenta accreta in mothers with a history of cesarean section. European Journal of Translational Myology, 28(4). https://doi.org/10.4081/ejtm.2018.7772

Downloads

Download data is not yet available.

Citations